002019 億帆醫藥
按盤價 
12.470 +0.470 (+3.917%)
12.470 +0.470 (+3.917%) | 2024/03 - 三個月 人民幣(K¥) | 與去年同期 比較 | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | 2020/12 人民幣(K¥) | ||
| 營業總收入 | 1,325,969 | 41.28% | 4,068,107 | 3,836,641 | 4,409,036 | 5,400,381 | |
| 減：營業總成本 | 1,189,456 | 33.23% | 4,041,934 | 3,650,259 | 4,183,747 | 4,436,702 | |
| 其中:營業成本 | 697,907 | 45.17% | 2,121,933 | 1,970,701 | 2,580,651 | 2,890,466 | |
| 財務費用 | 17,329 | -2.61% | 58,828 | 22,237 | 72,224 | 67,324 | |
| 資產減值損失 | (4,285) | 250.94% | (887,364) | (111,543) | (48,272) | (10,370) | |
| 公允價值變動收益 | -- | -- | 10 | 502 | (14) | (14) | |
| 投資收益 | (4,561) | -4.35% | (15,069) | (18,135) | (4,476) | 6,947 | |
| 其中：對聯營企業和合營企業的投資收益 | (4,521) | -0.55% | (19,233) | (18,135) | (18,341) | 110 | |
| 營業利潤 | 158,853 | 258.35% | (882,712) | 143,808 | 212,198 | 1,084,556 | |
| 利潤總額 | 158,914 | 251.26% | (869,031) | 156,737 | 210,789 | 1,080,713 | |
| 減：所得稅費用 | 41,365 | 3,206.94% | 16,619 | 29,651 | (31,425) | 149,319 | |
| 淨利潤 | 117,548 | 167.22% | (885,649) | 127,085 | 242,214 | 931,394 | |
| 減：非控股權益 | (28,551) | 37.37% | (334,576) | (64,133) | (36,185) | (36,997) | |
| 股東淨利潤 | 146,099 | 125.55% | (551,073) | 191,218 | 278,399 | 968,391 | |
市場價值指標 | |||||||
| 每股收益 (元) * | 0.120 | 126.18% | -0.450 | 0.160 | 0.230 | 0.800 | |
| 每股派息 (元) * | -- | -- | -- | -- | -- | 0.050 | |
| 每股淨資產 (元) * | 6.858 | -5.10% | 6.750 | 7.187 | 6.916 | 6.836 | |
| 審計意見 # | -- | 标准的无保留意见 | 标准的无保留意见 | 标准的无保留意见 | 标准的无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 報價延遲最少15分鐘，資料更新時間為 05/07/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
